跳至主要内容
临床试验/NCT01285011
NCT01285011已完成不适用

Short Term Follow-up of Patient Implanted With the Proximal Interphalangeal

Integra LifeSciences Services5 个研究点 分布在 3 个国家目标入组 156 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
156
试验地点
5
主要终点
Rate of device related complications

研究概览

简要总结

Hammertoe and ClawToe are ones of the most common foot deformities. The second toe is the most frequently affected, but the other small toes may also be involved. When nonoperative treatment fails, surgery often is recommended. One surgical option is the arthrodesis of the Proximal Interphalangeal (PIP) joint. This arthrodesis is technically demanding, its needs:

  • Internal fixation;
  • Interphalangeal Compression;
  • Anatomic PIP joint plantar flexion angle. The implant Ipp-On has been developed for this specific arthrodesis. The objective of this study is to evaluate the efficacy and safety of the Proximal Interphalangeal Implant: Ipp-On at short term follow up.

The safety of the Ipp-On will be described in terms of rate of device related complications.

The efficacy of the Ipp-On will be described in terms of fusion rate at 6 months.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient who needs a proximal interphalangeal joint arthrodesis for whose surgeon has recommended that a proximal Interphalangeal Implant Ipp-On be implanted
  • Age >= 18 years
  • Have willingness to give his/her Data Transfer Authorization

排除标准

  • Contraindication of the implantation of the Ipp-On The implant should not be used in a patient who has currently, or who has a history of: • Active local or systemic infection
  • Severe peripheral vascular disease
  • Severe longitudinal deformity
  • Insufficient quantity or quality of bone to permit stabilization of the arthrodesis
  • Conditions that restrict the patient's ability or willingness to follow postoperative instructions during the healing process
  • Suspected or documented metal allergy or intolerance.
  • History of prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol

结局指标

主要结局

Rate of device related complications

时间窗: 12 months

fusion rate

时间窗: 6 months

次要结局

  • Subjective assessment(6 months/12 months)
  • Clinical Assessment(6 months/12 months)
  • Fusion rate(3 months)
  • American Orthopaedic Foot and Ankle Society Lesser Metatarsophalangeal Scale (AOFAS LMIS) score(6 months/12 months)
  • Radiological Evaluation(6 months/12 months)

研究者

发起方
Integra LifeSciences Services
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验